Analisis Faktor - Faktor Yang Mempengaruhi Kepatuhan Masyarakat Dalam Membayar Pbb Di Kota Medan
DAFTAR PUSTAKA
Abe, C., I. Kobayashi, S. Mitarai, M. Wada, Y. Kawabe, T. Takashima, K.
Suzuki, L-H Sng, S. Wang, H H Htay, dan H. Ogata. 2008. Biological and
Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates
with Low-Level Resistance to Isoniazid in Japan. J. Clin. Microbiol
46(7):2263-2268.
Ahmad, S., E. Fares, G. F. Araj, T. D. Chugh dan A. S. Mustafa. 2002.
Prevalence of S315T mutation within the katG gene in isoniazid-resistant
clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Int J
Tuberc Lung Dis. 6(10):920-926.
Al-Hajjaj, M. S dan I. M. Al-Khatim. 2000. High rate of non-compliance with
anti-tuberculosis treatment despite a retrieval system: a call for
implementation of directly observed therapy in Saudi Arabia. Int J Tuberc
Lung Dis. 4(4):345–349.
Amin, A. G., R. Goude, L. Shi, J. Zhang, D. Chatterjee dan T. Parish. 2008.
EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis.
Microbiology:Society for General Microbiology Journals.154(1): 240-248.
Ananthanarayan, R dan C. K. J. Paniker. 2005. Textbook of Microbiology.7th ed.
Orient Longman Private Ltd. Hiderabad.
Andina, M. 2012. Deteksi Mycobacterium tuberculosis Pada Sputum Penderita
Tuberculosis Paru Basil Tahan Asam Negatif Dengan Reaksi Rantai
Polimerase. Program Studi Magister Biomedik Fakultas Kedokteran
Universitas Sumatera Utara. Medan.
Becker, C., J. B. Dressman, G. L. Amidon, H.E. Junginger, S. Kopp, K.K. midha,
V. P. Shah, S. Stavchansky dan D.M. Barends. 2006. Biowaiver
Monographs for Immediate Release Solid Oral Dosage Forms: Isoniazid.
Journal of Pharmaceutical Sciences. 96(3):522-531.
Bello, S. I dan O. A. Itiola. 2010. Drug adherence amongs tuberculosis patients in
the university of Ilorin Teaching Hospital, Ilorin, Nigeria. African Journal
of Pharmacy and Pharmacology. 4(3):109-144.
Bostanabad, S. Z., L. P. Titov, A. Bahrmand dan S. A. Nojoumi. 2008. Detection
of mutation in isoniazid-resistant Mycobacterium tuberculosis isolates from
tuberculosis patients in Belarus. Indian Journal of Medical Microbiology.
26(2):143-147.
Briken, V., S. A. Porcelli, G. S. Besra dan L. Kremer. 2004. Mycobacterial
lipoarabinomannan and related lipoglycans: from biogenesis to modulation
of the immune response. Molecular Microbiology. 53(2):391-403.
Brooks, G. F., K.C. Carrol, J. S. Butel, S. A. Morse. Jawetz, Melnick dan
Adelberg. 2007. Medical Microbiology. 24th ed. McGraw-Hill Companies,
Inc. USA.
Burman, W. J., D. L. Cohn, C. A. Rietmeijer, F. N. Judson, J. A. Sbarbaro dan R.
R. Reves. 1997. Noncompliance With Directly Observed Therapy for
Tuberculosis. Chest. 111:1168-1173.
Chuah SY. 1991. Factors associated with poor patient compliance with
antituberculosis therapy in Northwest Perak, Malaysia. Tubercle. 72: 261264.
Colangeli, R., V. L. Arcus, R. T. Cursons, A. Ruthe, N. Karalus, K. Coley, S. D.
Manning, S. Kim, E. Marchiano dan D. Alland. 2014. Whole Genome
Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low
Mutation Rates during Latent Infections in Humans.Plos One. 9(3):e91024.
Ensembl
Genomes.
2015.
Mycobacterium
tuberculosis
H37Rv.
http://bacteria.ensembl.org/mycobacterium_tuberculosis_h37rv_asm195
95v2. 16 juni 2015. (15.00).
Falzon, D., E. Jaramillo, H.J. Schu¨nemann, M. Arentz, M. Bauer, J. Bayona, L.
Blanc, J.A. Caminero, C.L. Daley, C. Duncombe, C. Fitzpatrick, A.
Gebhard, H. Getahun, M. Henkens, T.H. Holtz, J. Keravec, S. Keshavjee,
A.J. Khan, R. Kulier, V. Leimane, C. Lienhardt, C. Lu, A. Mariandyshev,
G.B.Migliori, F.Mirzayev, C.D. Mitnick, P. Nunn, G. Nwagboniwe, O.
Oxlade, D. Palmero, P. Pavlinac, M.I. Quelapio, M.C. Raviglione, M.L.
Rich, S. Royce, S. Ru¨sch-Gerdes, A. Salakaia, R. Sarin, D. Sculier, F.
Varaine, M. Vitoria, J.L. Walson, F. Wares, K. Weyer, R.A. White, dan M.
Zignol. 2011. WHO Guidelines for The Programmatic Management of
Drug-Resistant Tuberculosis: 2011 Update. European Respiratory Journal.
38(3):516-528.
FAD (Food and Drug Administration). 2013. Chemistry and Toxicology Devices,
Strip Test, Isoniazid – unclassified. Clinical Chemistry and Clinical
Toxicology Devices Panel of the Medical Devices Advisory Committee
Meeting Announcement. 25-26 April: 1-23.
Frank, J., Y. Hirsch-Moverman dan P. Colson. 2005. Adherence to treatment for
latent tuberculosis infection: a manual for healthcare providers. Charles P.
Felton National Tuberculosis Center. 1-54.
Gad, A., A. M. A. Mandil, A. A. R. Sherif, Z. M. Gad dan S. Sallam. 1997.
Compliance with antituberculosis drugs among tuberculosis patients in
Alexandria, Egypt. Eastern Mediterranean Health Journal. 3(2):244-250.
Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K.
Zeller, J. Andrews dan G. Friedland. 2006. Extensively drug-resistant
tuberculosis as a cause of death in patients co-infected with tuberculosis and
HIV in a rural area of South Africa. http://www.thelancet.com. 30 Februari
2014 (19:32).
Genbank. 2015. Mycobacterium tuberculosis H37Rv, complete genome.
http://www.ncbi.nlm.nih.gov/nuccore/NC_000962.3?report=genbank.
16
juni 2015. (15.12).
Goude, R dan T. Parish. 2008. The genetics of cell wall biosynthesis in
Mycobacterium tuberculosis. Future Microbiol. 3(3):299-313.
Guo, H., Q. Seet, S. Denkin, L. Parsons dan Y. Zhang. 2006. Molecular
characterization of isoniazid-resistant clinical isolates of Mycobacterium
tuberculosis from the USA. Journal of Medical Microbiology. 55:15271531.
Hanifa, Y., K. Mngadi, J. Lewis, K. Fielding, G. Churchyard dan A. D. Grant.
2007. Evaluation of the Arkansas method of urine testing for isoniazid in
South Africa. Int J Tuberc Lung Dis. 11(11):1232-1236.
Haynes, R.B., D. W. Taylor dan D. L. Sackett. 1979. Compliance in Health Care.
Baltimore, Maryland. Johns Hopkins University Press.
International Union Against Tuberculosis and Lung Disease (IUATLD). 2002.
Interventions for Tuberculosis Control and Elimination. Paris.
Jin, J., G. E. Sklar, V. M. S. Oh dan S. C. Li. 2008. Factors affecting therapeutic
compliance: A review from the patient’s perspective. Therapeutics and
Clinical Risk Management. 4(1):269–286.
Kardas, P dan W. R. Bishai. 2006. Compliance in anti-infective medicine. Adv
Stud Med. 6(7): S652-S658.
Kementerian Kesehatan RI. 2011. Pedoman Nasional Pengendalian Tuberculosis.
Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan.
Jakarta..
Kementerian Kesehatan RI. 2012. Modul Pelatihan Pemeriksaan Dahak
Mikroskopik TB. Direktorat Jendral Pengendalian Penyakit dan Penyehatan
Lingkungan. Jakarta.
Lina, M. R., B. Bela dan A. Yasmon. 2009. Deteksi mutasi gen KatG
Mycobacterium tuberculosis dengan metode PCR (polymerase chain
reaction) - Hibridisasi dot blot menggunakan pelacak oligonukleotida
bertanda 32P. Scientific Journal for The Applications of Isotopes and
Radiation. 5(1):54-67.
Lisdawati, V., I. Parwati, P. Sudarmon, T. M. Sudiro, R. Ramadhany1, N.
Puspandari, L. Rif’ati1 dan Triyani S. 2010. Studi Pemetaan Awal DNA
Mycobacterium tuberculosis complex Secara Spoligotyping Pada Hasil
Isolasi Dahak Pasien Tuberkulosis Paru Dari 10 Ibu Kota Propinsi (Bagian
I). Buletin Penelitian Kesehatan. 38(4):169-185.
Levy, S. B., 2002. Factors impacting on the problem of antibiotic resistance.
Journal of Antimicrobial Chemoteraphy. 49:25-30.
Marahatta, S.B., S. Gautam, S. Dhital, N. Pote, A. K. Jha, R. Mahato, S. Mishra,
B. H. Poudel, P. Ramasoota, J. Kaewkungwal dan P. Singhasivanon. 2011.
KatG (SER 315 THR) Gene Mutation in Isoniazid Resistant Mycobacterium
tuberculosis. Kathmandu Univ Med J. 9(1):19-23.
Meissner, PE., P. Musoke, A. Okwera, J. E. G. Bunn dan J. B. S. Coulter. 2002.
The value of urine testing for verifying adherence to anti-tuberculosis
chemotherapy in children and adults in Uganda. Int J Tuberc Lung Dis.
6(10):903–908.
Mikusová, K., M. Belánová, J. Kordulákova, K. Honda, M. R. McNeil, S.
Mahapatra, D. C. Crick dan P. J. Brennan. 2006. Identification of a Novel
Galactosyl Transferase Involved in Biosynthesis of the Mycobacterial Cell
Wall. Journal of Bacteriology. 188(18):6592-6598.
Mokrousov, I., T. Otten, M. Filipenko, A. Vyazovaya, E. Chrapov, E.
Limeschenko, L. Steklova, B. Vyshnevskiy dan O. Narvskaya. 2002.
Detection of Isoniazid-Resistant Mycobacterium tuberculosis Strains by a
Multiplex Allele-Specific PCR Assay Targeting katG Codon 315 Variation.
Journal of Clinical Microbiology. 40(7):2509-2512.
Munoz, E. B., M. F. Dorado, J. E. Guerreroc dan F. M. Martínez. 2014. The
effect of an educational intervention to improve patient antibiotic adherence
during dispensing in a community pharmacy. Aten Primaria. 46(7):367-375.
Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. V. Soolingen, dan
J. D. A. van Embden. 1996. Characterization of the Catalase-Peroxidase
Gene (katG) and inhA Locus in Isoniazid-Resistant and -Susceptible Strains
of Mycobacterium tuberculosis by Automated DNA Sequencing: Restricted
Array of Mutations Associated with Drug Resistance. The Journal of
Infectious Diseases. 173:196-202.
Musser, J. M. 1995. Antimikrobial Agent Resistance in Mycobacteria: Molecular
Genetic Insights. Clinical Microbiology Review. 8(4):496-514.
Naing, N. N., C. D’Este, A. R. Isa, R. Salleh, N. Bakar dan M. R. Mahmod. 2001.
Factors contributing to poor compliance with anti-tb treatment among
tuberculosis patients. Southeast Asian J Trop Med Public Health. 32(2):369382.
Portillo, P. D., A. Reyes, L. Salazar, M. D. C. Menendez dan M. J. Garcia. 2007.
Genomics and Proteomix. Tuberculosis 2007, From Basic Science to Patient
Care. www.tuberculosistextbook.com. 14 Desember 2012 (14:33).
Preziosi, P. 2007. Isoniazid: Metabolic Aspects and Toxicological Correlates.
Current drug metabolism. Bentham Science Publishers Ltd .8(8):839-851.
Prianty, I. R., S. Muda dan Rasmaliah. 2012. Karakteristik penderita tuberkulosis
paru pada balita yang dirawat inap di Rumah Sakit Vita Insani Pematang
Siantar tahun 2010-2012. Departemen Epidemiologi FKM Universitas
Sumatera Utara. Medan.
Public Health Agency of Canada. 2010. Mycobacterium tuberculosis complex:
Pathogen Safety Data Sheet – Infectious Substances. http://www.phacaspc.gc.ca/lab-bio/res/psds-ftss/tuber-eng.php. 27 Oktober 2013 (22.34).
Ragheb, M. N, C. B. Ford, M. R. Chase, P. L. Lin dan J. L. Flynn. 2013. The
mutation rate of mycobacterial repetitive unit loci in strains of M.
tuberculosis from cynomolgus macaque infection. BMC Genomics.
14(145):1471-2164.
Ramaswamy, S dan J. M. Musser. 1998. Molecular genetic basis ofantimicrobial
agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and
Lung Disease. 79(1):3-29.
Ramaswamy, S. V., R. Reich, S-J. Dou, L. Jasperse, X. Pan, A. Wanger, T.
Quitugua dan E. A. Graviss. 2003. Single Nucleotide Polymorphisms in
Genes Assosiated with Isoniazid Resistance in Mycobacterium
tuberculosis.Antimicroba. Agents Chemother. 47(4):1241-1250.
Rattan, A., A. Kalia dan N. Ahmad. 1999. Multidrug-resistant Mycobacterium
tuberculosis: molecular perspectives. Ind. J. Tub. 46(51):51-68.
Rie, A.V., R. Warren, I. Mshanga, A. M. Jordaan, G. D. Van der Spuy, M.
Richardson, J. Simpson, R. P. Gie, D. A. Enarson, N. Beyers, P. D. Van
Helden dan T. C. Victor. 2001. Analysis for a Limited Number of Gene
Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a
High-Incidence Community. J. Clin. Microbiol 39(2):636-641.
Ryan, K.J. dan C.G. Ray. 2010. Sherris Medical Microbiology. 5th ed. McGrawHill Companies, Inc. USA.
Sacco, E., A. S. Covarrubias, H. M. O’Hare, P. Carroll, N. Eynard, T. A. Jones,T.
Parish, M. Daffe, K. Backbro dan A. Quemard. 2007. The missing piece of
the type II fatty acid synthase system from Mycobacterium tuberculosis.
Proceedings of National Academy of Sciences of the United States of
America. 104(37):14628–14633.
Schraufnagel, D. E., R. Stoner, E. Whiting, G. S-Torbeck dan M. J. Werhane.
1990. Testing for lsoniazid* An Evaluation of the Arkansas Method. Chest.
96(2):314-316.
Shrestha, R., R. N. Joshi1, K. Joshi, B. H. Poudel, dan B. G.Shrestha. 2011.
Analysis of KatG Ser315Thr Mutation in Multidrug Resistant
Mycobacterium tuberculosis and SLC11A1 Polymorphism in Multidrug
Resistance Tuberculosis in Central Development Region of Nepal Using
PCR‐RFLP Technique: A Pilot Study. Nepal Journal of Biotechnology.
1(1):14‐21.
Sihombing, H. 2011. Pola Resistensi Primer Pada Penderita TB Paru Kategori I di
RSUP H. Adam Malik Medan. Tesis. Program Pendidikan Dokter Spesialis
Departemen Pulmonologi & Ilmu Kedokteran Respirasi Fakultas
Kedokteran Universitas Sumatera Utara. Medan.
Sjahrurachman, A. 2010. Diagnosis “Multidrug Resistant Mycobacterium”
Tuberculosis. Jurnal Tuberkulosis Indonesia. 7(2):8-11.
Soepandi, P. Z. 2010. Diagnosis dan faktor yang mempengaruhi terjadinya TBMDR. Jurnal Tuberkulosis Indonesia. 7(2):16-19.
Stephenson, B. J., B. H. Rowe, R. B. Haynes, W. M. Macharia dan G. Leon.
1993. Is This Patient Taking the Treatment as Prescribed?. The Journal of
The American Medical Assosiation. 269(21):2779-2781.
Suswati, E. 2006. Hubungan tingkat pendidikan dengan kepatuhan minum obat
pada penderita tuberkulosis paru. ©Pengembangan Pendidikan. 3(1):67-73.
Sweetman, S. C. 2009. Martimdale. The Complete Drug Reference. 36th ed.
Pharmaceutical Press. London.
Teixeira, R. L. F., M. Q. P. Lopes, P. N. Suffys dan A. R. Santos. 2013.
Tuberculosis
Pharmacogenetics:
State
of
The
Art.
http://dx.doi.org/10.5772/54984. 23 Oktober 2013 (20.33).
Uniprot. 2015. Catalase-peroxidase - katG - Mycobacterium tuberculosis (strain
ATCC 25618 / H37Rv) Version 4. http://www.uniprot.org/uniprot/P9WIE5.
25 Juli 2015. (13.28).
Wang, J. Y., R. M. Burger dan K. Drlica. 1997. Role of Superoxide in CatalasePeroxidase-Mediated Isoniazid Action against Mycobacteria. Antimicrob.
Agents Chemother. 42(3):709-711.
Warianto, C. 2013. Mutasi. http://www.konsepbiologi.wordpress.com. 2 Mei 2014
(20.25).
World Health Organization (WHO). 2003. Adherence to long-term therapies:
Evidance for action. http://www.who.int/tb/data. 23 Oktorber 2013 (13:50).
World Health Organization (WHO). 2014. Global Tuberculosis Report 2014.
WHO Press. Switzerland.
World Health Organization (WHO). 2013. Definition and reporting framework for
tuberculosis – 2013 revision. http://www.who.int. 22 November 2012
(14:01).
World Health Organization (WHO). 2014. Tuberculosis control in the South-East
Asia Region: Annual Report 2014.http://www.who.int. 22 November 2012
(15:00).
World Health Organization (WHO). 2014. Global Tuberculosis Report 2014:
Drug Resistant TB Survaillence and Response. .http://www.who.int. 3 April
2015 (09:00).
Wright, G. D. 2012. Back to the future: a new ‘old’ lead for tuberculosis. EMBO
Mol Med. 4:1029-1031.
Abe, C., I. Kobayashi, S. Mitarai, M. Wada, Y. Kawabe, T. Takashima, K.
Suzuki, L-H Sng, S. Wang, H H Htay, dan H. Ogata. 2008. Biological and
Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates
with Low-Level Resistance to Isoniazid in Japan. J. Clin. Microbiol
46(7):2263-2268.
Ahmad, S., E. Fares, G. F. Araj, T. D. Chugh dan A. S. Mustafa. 2002.
Prevalence of S315T mutation within the katG gene in isoniazid-resistant
clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Int J
Tuberc Lung Dis. 6(10):920-926.
Al-Hajjaj, M. S dan I. M. Al-Khatim. 2000. High rate of non-compliance with
anti-tuberculosis treatment despite a retrieval system: a call for
implementation of directly observed therapy in Saudi Arabia. Int J Tuberc
Lung Dis. 4(4):345–349.
Amin, A. G., R. Goude, L. Shi, J. Zhang, D. Chatterjee dan T. Parish. 2008.
EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis.
Microbiology:Society for General Microbiology Journals.154(1): 240-248.
Ananthanarayan, R dan C. K. J. Paniker. 2005. Textbook of Microbiology.7th ed.
Orient Longman Private Ltd. Hiderabad.
Andina, M. 2012. Deteksi Mycobacterium tuberculosis Pada Sputum Penderita
Tuberculosis Paru Basil Tahan Asam Negatif Dengan Reaksi Rantai
Polimerase. Program Studi Magister Biomedik Fakultas Kedokteran
Universitas Sumatera Utara. Medan.
Becker, C., J. B. Dressman, G. L. Amidon, H.E. Junginger, S. Kopp, K.K. midha,
V. P. Shah, S. Stavchansky dan D.M. Barends. 2006. Biowaiver
Monographs for Immediate Release Solid Oral Dosage Forms: Isoniazid.
Journal of Pharmaceutical Sciences. 96(3):522-531.
Bello, S. I dan O. A. Itiola. 2010. Drug adherence amongs tuberculosis patients in
the university of Ilorin Teaching Hospital, Ilorin, Nigeria. African Journal
of Pharmacy and Pharmacology. 4(3):109-144.
Bostanabad, S. Z., L. P. Titov, A. Bahrmand dan S. A. Nojoumi. 2008. Detection
of mutation in isoniazid-resistant Mycobacterium tuberculosis isolates from
tuberculosis patients in Belarus. Indian Journal of Medical Microbiology.
26(2):143-147.
Briken, V., S. A. Porcelli, G. S. Besra dan L. Kremer. 2004. Mycobacterial
lipoarabinomannan and related lipoglycans: from biogenesis to modulation
of the immune response. Molecular Microbiology. 53(2):391-403.
Brooks, G. F., K.C. Carrol, J. S. Butel, S. A. Morse. Jawetz, Melnick dan
Adelberg. 2007. Medical Microbiology. 24th ed. McGraw-Hill Companies,
Inc. USA.
Burman, W. J., D. L. Cohn, C. A. Rietmeijer, F. N. Judson, J. A. Sbarbaro dan R.
R. Reves. 1997. Noncompliance With Directly Observed Therapy for
Tuberculosis. Chest. 111:1168-1173.
Chuah SY. 1991. Factors associated with poor patient compliance with
antituberculosis therapy in Northwest Perak, Malaysia. Tubercle. 72: 261264.
Colangeli, R., V. L. Arcus, R. T. Cursons, A. Ruthe, N. Karalus, K. Coley, S. D.
Manning, S. Kim, E. Marchiano dan D. Alland. 2014. Whole Genome
Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low
Mutation Rates during Latent Infections in Humans.Plos One. 9(3):e91024.
Ensembl
Genomes.
2015.
Mycobacterium
tuberculosis
H37Rv.
http://bacteria.ensembl.org/mycobacterium_tuberculosis_h37rv_asm195
95v2. 16 juni 2015. (15.00).
Falzon, D., E. Jaramillo, H.J. Schu¨nemann, M. Arentz, M. Bauer, J. Bayona, L.
Blanc, J.A. Caminero, C.L. Daley, C. Duncombe, C. Fitzpatrick, A.
Gebhard, H. Getahun, M. Henkens, T.H. Holtz, J. Keravec, S. Keshavjee,
A.J. Khan, R. Kulier, V. Leimane, C. Lienhardt, C. Lu, A. Mariandyshev,
G.B.Migliori, F.Mirzayev, C.D. Mitnick, P. Nunn, G. Nwagboniwe, O.
Oxlade, D. Palmero, P. Pavlinac, M.I. Quelapio, M.C. Raviglione, M.L.
Rich, S. Royce, S. Ru¨sch-Gerdes, A. Salakaia, R. Sarin, D. Sculier, F.
Varaine, M. Vitoria, J.L. Walson, F. Wares, K. Weyer, R.A. White, dan M.
Zignol. 2011. WHO Guidelines for The Programmatic Management of
Drug-Resistant Tuberculosis: 2011 Update. European Respiratory Journal.
38(3):516-528.
FAD (Food and Drug Administration). 2013. Chemistry and Toxicology Devices,
Strip Test, Isoniazid – unclassified. Clinical Chemistry and Clinical
Toxicology Devices Panel of the Medical Devices Advisory Committee
Meeting Announcement. 25-26 April: 1-23.
Frank, J., Y. Hirsch-Moverman dan P. Colson. 2005. Adherence to treatment for
latent tuberculosis infection: a manual for healthcare providers. Charles P.
Felton National Tuberculosis Center. 1-54.
Gad, A., A. M. A. Mandil, A. A. R. Sherif, Z. M. Gad dan S. Sallam. 1997.
Compliance with antituberculosis drugs among tuberculosis patients in
Alexandria, Egypt. Eastern Mediterranean Health Journal. 3(2):244-250.
Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K.
Zeller, J. Andrews dan G. Friedland. 2006. Extensively drug-resistant
tuberculosis as a cause of death in patients co-infected with tuberculosis and
HIV in a rural area of South Africa. http://www.thelancet.com. 30 Februari
2014 (19:32).
Genbank. 2015. Mycobacterium tuberculosis H37Rv, complete genome.
http://www.ncbi.nlm.nih.gov/nuccore/NC_000962.3?report=genbank.
16
juni 2015. (15.12).
Goude, R dan T. Parish. 2008. The genetics of cell wall biosynthesis in
Mycobacterium tuberculosis. Future Microbiol. 3(3):299-313.
Guo, H., Q. Seet, S. Denkin, L. Parsons dan Y. Zhang. 2006. Molecular
characterization of isoniazid-resistant clinical isolates of Mycobacterium
tuberculosis from the USA. Journal of Medical Microbiology. 55:15271531.
Hanifa, Y., K. Mngadi, J. Lewis, K. Fielding, G. Churchyard dan A. D. Grant.
2007. Evaluation of the Arkansas method of urine testing for isoniazid in
South Africa. Int J Tuberc Lung Dis. 11(11):1232-1236.
Haynes, R.B., D. W. Taylor dan D. L. Sackett. 1979. Compliance in Health Care.
Baltimore, Maryland. Johns Hopkins University Press.
International Union Against Tuberculosis and Lung Disease (IUATLD). 2002.
Interventions for Tuberculosis Control and Elimination. Paris.
Jin, J., G. E. Sklar, V. M. S. Oh dan S. C. Li. 2008. Factors affecting therapeutic
compliance: A review from the patient’s perspective. Therapeutics and
Clinical Risk Management. 4(1):269–286.
Kardas, P dan W. R. Bishai. 2006. Compliance in anti-infective medicine. Adv
Stud Med. 6(7): S652-S658.
Kementerian Kesehatan RI. 2011. Pedoman Nasional Pengendalian Tuberculosis.
Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan.
Jakarta..
Kementerian Kesehatan RI. 2012. Modul Pelatihan Pemeriksaan Dahak
Mikroskopik TB. Direktorat Jendral Pengendalian Penyakit dan Penyehatan
Lingkungan. Jakarta.
Lina, M. R., B. Bela dan A. Yasmon. 2009. Deteksi mutasi gen KatG
Mycobacterium tuberculosis dengan metode PCR (polymerase chain
reaction) - Hibridisasi dot blot menggunakan pelacak oligonukleotida
bertanda 32P. Scientific Journal for The Applications of Isotopes and
Radiation. 5(1):54-67.
Lisdawati, V., I. Parwati, P. Sudarmon, T. M. Sudiro, R. Ramadhany1, N.
Puspandari, L. Rif’ati1 dan Triyani S. 2010. Studi Pemetaan Awal DNA
Mycobacterium tuberculosis complex Secara Spoligotyping Pada Hasil
Isolasi Dahak Pasien Tuberkulosis Paru Dari 10 Ibu Kota Propinsi (Bagian
I). Buletin Penelitian Kesehatan. 38(4):169-185.
Levy, S. B., 2002. Factors impacting on the problem of antibiotic resistance.
Journal of Antimicrobial Chemoteraphy. 49:25-30.
Marahatta, S.B., S. Gautam, S. Dhital, N. Pote, A. K. Jha, R. Mahato, S. Mishra,
B. H. Poudel, P. Ramasoota, J. Kaewkungwal dan P. Singhasivanon. 2011.
KatG (SER 315 THR) Gene Mutation in Isoniazid Resistant Mycobacterium
tuberculosis. Kathmandu Univ Med J. 9(1):19-23.
Meissner, PE., P. Musoke, A. Okwera, J. E. G. Bunn dan J. B. S. Coulter. 2002.
The value of urine testing for verifying adherence to anti-tuberculosis
chemotherapy in children and adults in Uganda. Int J Tuberc Lung Dis.
6(10):903–908.
Mikusová, K., M. Belánová, J. Kordulákova, K. Honda, M. R. McNeil, S.
Mahapatra, D. C. Crick dan P. J. Brennan. 2006. Identification of a Novel
Galactosyl Transferase Involved in Biosynthesis of the Mycobacterial Cell
Wall. Journal of Bacteriology. 188(18):6592-6598.
Mokrousov, I., T. Otten, M. Filipenko, A. Vyazovaya, E. Chrapov, E.
Limeschenko, L. Steklova, B. Vyshnevskiy dan O. Narvskaya. 2002.
Detection of Isoniazid-Resistant Mycobacterium tuberculosis Strains by a
Multiplex Allele-Specific PCR Assay Targeting katG Codon 315 Variation.
Journal of Clinical Microbiology. 40(7):2509-2512.
Munoz, E. B., M. F. Dorado, J. E. Guerreroc dan F. M. Martínez. 2014. The
effect of an educational intervention to improve patient antibiotic adherence
during dispensing in a community pharmacy. Aten Primaria. 46(7):367-375.
Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. V. Soolingen, dan
J. D. A. van Embden. 1996. Characterization of the Catalase-Peroxidase
Gene (katG) and inhA Locus in Isoniazid-Resistant and -Susceptible Strains
of Mycobacterium tuberculosis by Automated DNA Sequencing: Restricted
Array of Mutations Associated with Drug Resistance. The Journal of
Infectious Diseases. 173:196-202.
Musser, J. M. 1995. Antimikrobial Agent Resistance in Mycobacteria: Molecular
Genetic Insights. Clinical Microbiology Review. 8(4):496-514.
Naing, N. N., C. D’Este, A. R. Isa, R. Salleh, N. Bakar dan M. R. Mahmod. 2001.
Factors contributing to poor compliance with anti-tb treatment among
tuberculosis patients. Southeast Asian J Trop Med Public Health. 32(2):369382.
Portillo, P. D., A. Reyes, L. Salazar, M. D. C. Menendez dan M. J. Garcia. 2007.
Genomics and Proteomix. Tuberculosis 2007, From Basic Science to Patient
Care. www.tuberculosistextbook.com. 14 Desember 2012 (14:33).
Preziosi, P. 2007. Isoniazid: Metabolic Aspects and Toxicological Correlates.
Current drug metabolism. Bentham Science Publishers Ltd .8(8):839-851.
Prianty, I. R., S. Muda dan Rasmaliah. 2012. Karakteristik penderita tuberkulosis
paru pada balita yang dirawat inap di Rumah Sakit Vita Insani Pematang
Siantar tahun 2010-2012. Departemen Epidemiologi FKM Universitas
Sumatera Utara. Medan.
Public Health Agency of Canada. 2010. Mycobacterium tuberculosis complex:
Pathogen Safety Data Sheet – Infectious Substances. http://www.phacaspc.gc.ca/lab-bio/res/psds-ftss/tuber-eng.php. 27 Oktober 2013 (22.34).
Ragheb, M. N, C. B. Ford, M. R. Chase, P. L. Lin dan J. L. Flynn. 2013. The
mutation rate of mycobacterial repetitive unit loci in strains of M.
tuberculosis from cynomolgus macaque infection. BMC Genomics.
14(145):1471-2164.
Ramaswamy, S dan J. M. Musser. 1998. Molecular genetic basis ofantimicrobial
agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and
Lung Disease. 79(1):3-29.
Ramaswamy, S. V., R. Reich, S-J. Dou, L. Jasperse, X. Pan, A. Wanger, T.
Quitugua dan E. A. Graviss. 2003. Single Nucleotide Polymorphisms in
Genes Assosiated with Isoniazid Resistance in Mycobacterium
tuberculosis.Antimicroba. Agents Chemother. 47(4):1241-1250.
Rattan, A., A. Kalia dan N. Ahmad. 1999. Multidrug-resistant Mycobacterium
tuberculosis: molecular perspectives. Ind. J. Tub. 46(51):51-68.
Rie, A.V., R. Warren, I. Mshanga, A. M. Jordaan, G. D. Van der Spuy, M.
Richardson, J. Simpson, R. P. Gie, D. A. Enarson, N. Beyers, P. D. Van
Helden dan T. C. Victor. 2001. Analysis for a Limited Number of Gene
Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a
High-Incidence Community. J. Clin. Microbiol 39(2):636-641.
Ryan, K.J. dan C.G. Ray. 2010. Sherris Medical Microbiology. 5th ed. McGrawHill Companies, Inc. USA.
Sacco, E., A. S. Covarrubias, H. M. O’Hare, P. Carroll, N. Eynard, T. A. Jones,T.
Parish, M. Daffe, K. Backbro dan A. Quemard. 2007. The missing piece of
the type II fatty acid synthase system from Mycobacterium tuberculosis.
Proceedings of National Academy of Sciences of the United States of
America. 104(37):14628–14633.
Schraufnagel, D. E., R. Stoner, E. Whiting, G. S-Torbeck dan M. J. Werhane.
1990. Testing for lsoniazid* An Evaluation of the Arkansas Method. Chest.
96(2):314-316.
Shrestha, R., R. N. Joshi1, K. Joshi, B. H. Poudel, dan B. G.Shrestha. 2011.
Analysis of KatG Ser315Thr Mutation in Multidrug Resistant
Mycobacterium tuberculosis and SLC11A1 Polymorphism in Multidrug
Resistance Tuberculosis in Central Development Region of Nepal Using
PCR‐RFLP Technique: A Pilot Study. Nepal Journal of Biotechnology.
1(1):14‐21.
Sihombing, H. 2011. Pola Resistensi Primer Pada Penderita TB Paru Kategori I di
RSUP H. Adam Malik Medan. Tesis. Program Pendidikan Dokter Spesialis
Departemen Pulmonologi & Ilmu Kedokteran Respirasi Fakultas
Kedokteran Universitas Sumatera Utara. Medan.
Sjahrurachman, A. 2010. Diagnosis “Multidrug Resistant Mycobacterium”
Tuberculosis. Jurnal Tuberkulosis Indonesia. 7(2):8-11.
Soepandi, P. Z. 2010. Diagnosis dan faktor yang mempengaruhi terjadinya TBMDR. Jurnal Tuberkulosis Indonesia. 7(2):16-19.
Stephenson, B. J., B. H. Rowe, R. B. Haynes, W. M. Macharia dan G. Leon.
1993. Is This Patient Taking the Treatment as Prescribed?. The Journal of
The American Medical Assosiation. 269(21):2779-2781.
Suswati, E. 2006. Hubungan tingkat pendidikan dengan kepatuhan minum obat
pada penderita tuberkulosis paru. ©Pengembangan Pendidikan. 3(1):67-73.
Sweetman, S. C. 2009. Martimdale. The Complete Drug Reference. 36th ed.
Pharmaceutical Press. London.
Teixeira, R. L. F., M. Q. P. Lopes, P. N. Suffys dan A. R. Santos. 2013.
Tuberculosis
Pharmacogenetics:
State
of
The
Art.
http://dx.doi.org/10.5772/54984. 23 Oktober 2013 (20.33).
Uniprot. 2015. Catalase-peroxidase - katG - Mycobacterium tuberculosis (strain
ATCC 25618 / H37Rv) Version 4. http://www.uniprot.org/uniprot/P9WIE5.
25 Juli 2015. (13.28).
Wang, J. Y., R. M. Burger dan K. Drlica. 1997. Role of Superoxide in CatalasePeroxidase-Mediated Isoniazid Action against Mycobacteria. Antimicrob.
Agents Chemother. 42(3):709-711.
Warianto, C. 2013. Mutasi. http://www.konsepbiologi.wordpress.com. 2 Mei 2014
(20.25).
World Health Organization (WHO). 2003. Adherence to long-term therapies:
Evidance for action. http://www.who.int/tb/data. 23 Oktorber 2013 (13:50).
World Health Organization (WHO). 2014. Global Tuberculosis Report 2014.
WHO Press. Switzerland.
World Health Organization (WHO). 2013. Definition and reporting framework for
tuberculosis – 2013 revision. http://www.who.int. 22 November 2012
(14:01).
World Health Organization (WHO). 2014. Tuberculosis control in the South-East
Asia Region: Annual Report 2014.http://www.who.int. 22 November 2012
(15:00).
World Health Organization (WHO). 2014. Global Tuberculosis Report 2014:
Drug Resistant TB Survaillence and Response. .http://www.who.int. 3 April
2015 (09:00).
Wright, G. D. 2012. Back to the future: a new ‘old’ lead for tuberculosis. EMBO
Mol Med. 4:1029-1031.